94
Views
42
CrossRef citations to date
0
Altmetric
Original Article

High Circulating IL-6 Level in Graves' Ophthalmopathy

&
Pages 91-96 | Received 12 Dec 1995, Accepted 03 Aug 1996, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Oliver Dorado Cortez, Damien Grivet, Nicolas Perrillat, Philippe Gain & Gilles Thuret. (2023) Treatment of corticosteroid-resistant Graves’ orbitopathy with tocilizumab: a single-centre prospective study. Orbit 42:4, pages 411-417.
Read now
Mariya Asenova Stoynova, Alexander Dimitrov Shinkov, Georgi Kirilov Georgiev & Roussanka Dimitrova Kovatcheva. (2021) Association between Clinical Activity Score and Serum Interleukin-6, Interleukin-8 and Interleukin-10 during Systemic Glucocorticoid Treatment for Active Moderate-to-Severe Graves’ Orbitopathy. Current Eye Research 46:10, pages 1503-1508.
Read now
Fatemeh Rajaii, Allison N McCoy & Terry J Smith. (2014) Cytokines as villains and potential therapeutic targets in thyroid-associated ophthalmopathy: from bench to bedside. Expert Review of Ophthalmology 9:3, pages 227-234.
Read now
Katarzyna Lacka, Ewa Manuszewska, Izabela Korczowska & Jan K. Lacki. (2007) The Effect of Methylprednisolone Pulse Treatment on Cytokine Network in Graves Ophthalmopathy. Current Eye Research 32:3, pages 291-297.
Read now
Tomasz Bednarczuk, Alina Kuryłowicz, Yuji Hiromatsu, Jacek Kiljański, Anna Telichowska & Janusz Nauman. (2004) Association of G-174C Polymorphism of the Interleukin-6 Gene Promoter with Graves' Ophthalmopathy. Autoimmunity 37:3, pages 223-226.
Read now
R.A. Ajjan & A.P. Weetman. (2003) Cytokines in Thyroid Autoimmunity. Autoimmunity 36:6-7, pages 351-359.
Read now

Articles from other publishers (36)

Bita Mohammadi, Kamal Dua, Mohammadreza Saghafi, Sachin Kumar Singh, Zahra Heydarifard & Milad Zandi. (2023) COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms. Journal of Medical Virology 95:8.
Crossref
Pengbo Zhang & Huang Zhu. (2022) Cytokines in Thyroid-Associated Ophthalmopathy. Journal of Immunology Research 2022, pages 1-12.
Crossref
Hans Olav Ueland, Grethe Åstrøm Ueland, Kristian Løvås, Lars Ertesvåg Breivk, Alexander Stanley Thrane, Ann-Elin Meling Stokland, Eyvind Rødahl & Eystein Sverre Husebye. (2022) Novel inflammatory biomarkers in thyroid eye disease. European Journal of Endocrinology 187:2, pages 293-300.
Crossref
Niranjan Karthik Senthil Kumar, Senthamarai G & Samarapuri A. (2022) Correlation of clinical parameters and objective assessment tools in active thyroid eye disease – Prospective analytical study. IP International Journal of Ocular Oncology and Oculoplasty 8:1, pages 31-36.
Crossref
E. J. Neag & T. J. Smith. (2021) 2021 update on thyroid-associated ophthalmopathy. Journal of Endocrinological Investigation 45:2, pages 235-259.
Crossref
Tiago Borges, Arsénio Barbosa & Sérgio Silva. 2022. Translational Autoimmunity. Translational Autoimmunity 83 114 .
Ildikó Molnár. 2021. Graves' Disease. Graves' Disease.
Nicholas R. Mahoney & Fatemeh Rajaii. (2021) Current Management of Thyroid Eye Disease. Current Treatment Options in Neurology 23:7.
Crossref
Charlene Y. C. Chau, Kendrick C. Shih, Loraine L. W. Chow & Victor H. F. Lee. (2020) Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease. Ophthalmology and Therapy 10:1, pages 5-12.
Crossref
Yi-Hsuan Wei, Shu-Lang Liao, Chia-Chun Wang, Sen-Hsu Wang, Wan-Chun Tang & Chang-Hao Yang. (2021) Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves’ Ophthalmopathy through the Regulation of FoxO3a Signaling. Mediators of Inflammation 2021, pages 1-12.
Crossref
Pui S. Chan, Qingqing Li, Bowen Zhang, Kenneth K.W. To & Sharon S.Y. Leung. (2020) In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model. European Journal of Pharmaceutics and Biopharmaceutics 155, pages 190-198.
Crossref
John Y. Lee, Ryan A. Gallo, Paul J. Ledon, Wensi Tao, David T. Tse, Daniel Pelaez & Sara T. Wester. (2020) Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy. Translational Vision Science & Technology 9:9, pages 39.
Crossref
Ildikó Molnár. (2020) Interactions among thyroid hormone (FT4), chemokine (MCP-1) and neurotrophin (NGF-β) levels studied in Hungarian postmenopausal and obese women. Cytokine 127, pages 154948.
Crossref
Alan Chun Hong Lee & George J. Kahaly. (2020) Novel Approaches for Immunosuppression in Graves’ Hyperthyroidism and Associated Orbitopathy. European Thyroid Journal 9:Suppl. 1, pages 17-30.
Crossref
Ildikó Molnár, József A. Szentmiklósi, Rudolf Gesztelyi & Éva Somogyiné-Vári. (2019) Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves’ disease influencing the therapeutic efficacy. Clinical and Experimental Medicine 19:2, pages 245-254.
Crossref
Safikur Rahman, Ayyagari Archana, Arif Tasleem Jan, Durgashree Dutta, Abhishek Shankar, Jihoe Kim & Rinki Minakshi. (2019) Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress. Frontiers in Immunology 10.
Crossref
Edina Kishazi, Marianne Dor, Simone Eperon, Aurélie Oberic, Natacha Turck & Mehrad Hamedani. (2018) Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy. Scientific Reports 8:1.
Crossref
Utta Berchner-Pfannschmidt, Sajad Moshkelgosha, Salvador Diaz-Cano, Bärbel Edelmann, Gina-Eva Görtz, Mareike Horstmann, Alistair Noble, Wiebke Hansen, Anja Eckstein & J. Paul Banga. (2016) Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen. Endocrinology 157:4, pages 1673-1682.
Crossref
Yunhai Tu, Yilong Wang, Luna Ding, Jiao Zhang & Wencan Wu. (2016) Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy. PLOS ONE 11:2, pages e0148595.
Crossref
Kah Hie Wong, Shi Song Rong, Kelvin K. L. Chong, Alvin L. Young, Chi Pui Pang & Li Jia Chen. (2015) Genetic Associations of Interleukin-related Genes with Graves’ Ophthalmopathy: a Systematic Review and Meta-analysis. Scientific Reports 5:1.
Crossref
Nupur Raychaudhuri, Roshini Fernando & Terry J. Smith. (2013) Thyrotropin Regulates IL-6 Expression in CD34+ Fibrocytes: Clear Delineation of Its cAMP-Independent Actions. PLoS ONE 8:9, pages e75100.
Crossref
Dana Butnaru, José V. Pérez-Moreiras & Silvia Sánchez-Ramón. (2013) Anti-IL-6R therapy on Graves' ophthalmopathy. Clinical Immunology 147:2, pages 120-121.
Crossref
Nupur Raychaudhuri, Raymond S. Douglas & Terry J. Smith. (2010) PGE2 Induces IL-6 in Orbital Fibroblasts through EP2 Receptors and Increased Gene Promoter Activity: Implications to Thyroid-Associated Ophthalmopathy. PLoS ONE 5:12, pages e15296.
Crossref
Seema KumarReagan SchieferMichael J. CoenenRebecca S. Bahn. (2010) A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves' Orbital Preadipocyte Fibroblasts. Thyroid 20:1, pages 59-65.
Crossref
Terry J. SmithChieh Chih TsaiMei-Ju ShihShanli TsuiBeiling ChenRui HanVibha NaikChris S. KingChris PressShweta KamatRobert A. GoldbergRichard P. PhippsRaymond S. DouglasAndrew G. Gianoukakis. (2008) Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy. Thyroid 18:9, pages 983-988.
Crossref
Roy Moncayo & Helga Moncayo. (2007) A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease. BMC Musculoskeletal Disorders 8:1.
Crossref
Beiling Chen, Shanli Tsui & Terry J. Smith. (2005) IL-1β Induces IL-6 Expression in Human Orbital Fibroblasts: Identification of an Anatomic-Site Specific Phenotypic Attribute Relevant to Thyroid-Associated Ophthalmopathy. The Journal of Immunology 175:2, pages 1310-1319.
Crossref
R. A. Ajjan & A. P. Weetman. (2014) New understanding of the role of cytokines in the pathogenesis of Graves’ ophthalmopathy. Journal of Endocrinological Investigation 27:3, pages 237-245.
Crossref
Seema Kumar & Rebecca S. Bahn. (2003) Relative Overexpression of Macrophage-Derived Cytokines in Orbital Adipose Tissue from Patients with Graves’ Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism 88:9, pages 4246-4250.
Crossref
Yuji HiromatsuHiroo KakuIkuyo MiyakeShiro MurayamaEri Soejima. (2002) Role of Cytokines in the Pathogenesis of Thyroid-Associated Ophthalmopathy. Thyroid 12:3, pages 217-221.
Crossref
Rebecca S. Bahn. (2002) Thyrotropin Receptor Expression in Orbital Adipose/Connective Tissues from Patients with Thyroid-Associated Ophthalmopathy. Thyroid 12:3, pages 193-195.
Crossref
Soma C. JyonouchiRosanee W. ValyaseviDebra A. HarteneckCharyl M. DuttonRebecca S. Bahn. (2001) Interleukin-6 Stimulates Thyrotropin Receptor Expression in Human Orbital Preadipocyte Fibroblasts from Patients with Graves' Ophthalmopathy. Thyroid 11:10, pages 929-934.
Crossref
Yuji Hiromatsu & Tomasz Bednarczukt. 2001. Thyroid Eye Disease. Thyroid Eye Disease 45 65 .
Yuji Hiromatsu, Dame Yang, Tomasz Bednarczuk, Ikuyo Miyake, Kyohei Nonaka & Yoichi Inoue. (2000) Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy*. The Journal of Clinical Endocrinology & Metabolism 85:3, pages 1194-1199.
Crossref
A. Siddiqi, J. P. Monson, D. F. Wood, G. M. Besser & J. M. Burrin. (1999) Serum Cytokines in Thyrotoxicosis1. The Journal of Clinical Endocrinology & Metabolism 84:2, pages 435-439.
Crossref
Gregor Förster & George Kahaly. (1998) Endokrine Orbitopathie 1998Graves’ Ophthalmopathy 1998. Medizinische Klinik 93:6, pages 365-373.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.